Cystic Fibrosis Foundation Licenses Experimental Compound to AbbVie

Cystic Fibrosis Foundation Licenses Experimental Compound to AbbVie

Source: 
BioSpace
snippet: 

Chicago-based AbbVie announced plans for a strategic collaboration with the Cystic Fibrosis Foundation. AbbVie will work to develop a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator compound that it licensed from the Foundation.